Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1991-08-16
1993-06-29
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 5303913, A61K 4902, A61K 4300, C07K 1528
Patent
active
052232417
ABSTRACT:
The invention relates to a method of detecting early rejection of an allograft in a mammal by administering to the mammal a diagnostically effective amount of detectably labeled immunoglobulin or fragment thereof, wherein the immunoglobulin substantially accumulates at the site of allograft rejection. The method of the invention may also be used to monitor allograft rejection during immunosuppressive therapy in a mammal which has received an allograft or to localize areas involved in autoimmune disease or inflammation.
REFERENCES:
patent: 4864020 (1989-09-01), Canle et al.
patent: 4925648 (1990-05-01), Hanssen et al.
patent: 5002869 (1991-03-01), Schlossman et al.
Haber Edgar
Isobe Mitsuaki
Khaw Ban A.
Bristol--Myers Squibb Company
Stoll Robert L.
The General Hospital Corporation
Zmurko Matthew
LandOfFree
Method for early detection of allograft rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for early detection of allograft rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for early detection of allograft rejection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1753607